decisionhealth Newsletters, Part B News - 2004 Issue 8 (August)
You could see new payments for routine costs associated with clinical trials
Subscribe or sign in to view the full article.
Article Overview
This article explains proposed CMS guidance affecting Medicare payment for routine care services associated with certain clinical trials, with emphasis on Category A investigational device studies. It is relevant to physicians, coders, compliance staff, and billing teams who handle clinical trial-related reimbursement and Medicare coverage issues. The discussion focuses on how the proposed policy may affect routine costs, carrier payment decisions, and common barriers to payment for trial-related services.
Why This Topic Matters
Clinical trials can create coverage and billing questions when Medicare beneficiaries receive services that are medically necessary but occur in the context of investigational care. Understanding the policy direction described here can help providers and billing staff anticipate reimbursement issues and coverage review processes.
What You Will Learn
- How proposed Medicare policy changes relate to routine care costs in clinical trials
- What kinds of trial-associated services are discussed under CMS guidance
- Why clinical trial reimbursement can be difficult for physicians and facilities
- How coverage issues may arise when routine care and investigational items overlap
Who Should Read This
- Physicians
- Medical coders
- Billing staff
- Compliance teams
- Practice managers
- Hospital revenue cycle staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com